0
0

Finn Sawyer Access to Cancer Testing Act

12/21/2024, 9:05 AM

Summary of Bill HR 1780

Bill 118 HR 1780, also known as the Finn Sawyer Access to Cancer Testing Act, aims to improve access to cancer testing for individuals in the United States. The bill was introduced by Representative Finn Sawyer and has garnered bipartisan support in Congress.

The key provisions of the bill include increasing funding for cancer testing programs, expanding access to genetic testing for individuals at high risk of developing cancer, and promoting research on new and innovative cancer testing technologies. The bill also seeks to improve coordination between healthcare providers and researchers to ensure that individuals receive timely and accurate cancer testing.

One of the main goals of the Finn Sawyer Access to Cancer Testing Act is to reduce barriers to cancer testing, particularly for underserved communities and individuals with limited access to healthcare. By increasing funding and promoting research in this area, the bill aims to improve early detection and treatment of cancer, ultimately saving lives and reducing healthcare costs. Overall, the Finn Sawyer Access to Cancer Testing Act is a comprehensive piece of legislation that seeks to address the challenges faced by individuals seeking cancer testing in the United States. With its focus on increasing access, funding, and research in this critical area, the bill has the potential to make a significant impact on the fight against cancer.

Congressional Summary of HR 1780

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Current Status of Bill HR 1780

Bill HR 1780 is currently in the status of Bill Introduced since March 24, 2023. Bill HR 1780 was introduced during Congress 118 and was introduced to the House on March 24, 2023.  Bill HR 1780's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 1780

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
36
Democrat Cosponsors
26
Republican Cosponsors
10
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 1780

Primary Policy Focus

Health

Potential Impact Areas

- Cancer
- Health care costs and insurance
- Health care coverage and access
- Health promotion and preventive care
- Medicaid
- Medical tests and diagnostic methods
- Medicare
- Poverty and welfare assistance
- State and local government operations

Alternate Title(s) of Bill HR 1780

Finn Sawyer Access to Cancer Testing Act
Finn Sawyer Access to Cancer Testing Act
To facilitate the development of treatments for cancer, and for other purposes.

Comments